chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Started having severe heart palpitations, my body got really really hot, I felt really really sick, my blood pressure was high, and I started to have a migraine.  Started around 11pm  the day of injection and lasted until 5am the day after injection
1:30am chills/fever/body aches  3:30am-12pm  nauseas/vomiting/headache/tiredness
5 cm redness, warmth, swelling left arm where DTaP vaccine given. 5 times bigger about 6 hours after shot.
pt exp fever & redness in lt arm mostly in elbow area; arm is swollen; pt notififed MD of arm discomfort on 19JUN then came in office on 21JUN93;
Given 0.5 ML of Moderna Covid-19 IZ, as directed, rather than 0.25mL. No known adverse reaction or symptoms.
Back pain; Redness ring on arm; Swelling of glands; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Redness ring on arm), BACK PAIN (Back pain) and LYMPHADENOPATHY (Swelling of glands) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced LYMPHADENOPATHY (Swelling of glands). On 16-Mar-2021, the patient experienced ERYTHEMA (Redness ring on arm). On an unknown date, the patient experienced BACK PAIN (Back pain). On 24-Mar-2021, ERYTHEMA (Redness ring on arm) and LYMPHADENOPATHY (Swelling of glands) had resolved. At the time of the report, BACK PAIN (Back pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant information reported. No treatment information reported.    Reporter did not allow further contact
fever, itching 3hr p/vax;rash & swelling of lips, wrist, ankles, knees, fingers on 8/14/99;
Severe pain with certain arm movements in arm muscle at the site of the vaccination.  The pain began the first evening of the vaccination, and lasted for about five (5) months.
Left side face numbness; hypertension; tachycardia; lightheadedness; This is a spontaneous report from a contactable other healthcare professional (patient himself). A 36-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: Elo140), intramuscularly at site of left arm at 11:15 on 19Dec2020 at single dose for COVID-19 immunization. Medical history included known allergies: environmental, sulfa. Concomitant medication included ibuprofen within 2 weeks of vaccination. The patient experienced left side face numbness, hypertension, tachycardia and lightheadedness, all at 10:00 on 05Jan2021. All events were identified as non-serious by reporter. The patient received lisinopril 10mg, electrocardiogram (EKG) and blood work for treatment. Facility where the most recent COVID-19 vaccine was administered was in hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The adverse event result in doctor or other healthcare professional office/clinic visit. Prior to vaccination, was the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The outcome of events was unknown.
Developed right upper arm pain, warmth and redness at injection site approximately 24 hours after vaccination. 2 days later, pain and redness above right elbow area and seen in ER. No redness noted at injection site. Diagnosed as possible cellulitiis. Rx with Keflex.
couldn't sleep; Felt sick; Fell; Body went stiff; Hit head on the wall; Vomiting; Fainted; Had seizures twice; Back pain; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of SYNCOPE (Fainted) and SEIZURE (Had seizures twice) in a 24-year-old female patient who received mRNA-1273  for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in October 2020.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Intramuscular) 1 dosage form. On 02-Apr-2021, the patient experienced BACK PAIN (Back pain). On 03-Apr-2021, the patient experienced SYNCOPE (Fainted) (seriousness criterion medically significant), SEIZURE (Had seizures twice) (seriousness criterion medically significant), INSOMNIA (couldn't sleep), MALAISE (Felt sick), FALL (Fell), MUSCULOSKELETAL STIFFNESS (Body went stiff), HEAD INJURY (Hit head on the wall) and VOMITING (Vomiting). At the time of the report, SYNCOPE (Fainted), SEIZURE (Had seizures twice), BACK PAIN (Back pain), INSOMNIA (couldn't sleep), MALAISE (Felt sick), FALL (Fell), MUSCULOSKELETAL STIFFNESS (Body went stiff), HEAD INJURY (Hit head on the wall) and VOMITING (Vomiting) outcome was unknown.        The action taken with mRNA-1273 (Intramuscular) was unknown.   For mRNA-1273 (Intramuscular), the reporter did not provide any causality assessments.   Labs included Electrocardiogram: and Urine analysis, no test results provided.  Treatment information not provided.  Company comment: Very limited information regarding these events has been provided at this time. Further information has been requested.; Sender's Comments: Very limited information regarding these events has been provided at this time. Further information has been requested.
injection site was a little itchy; soreness at the injection site; a slight little headache for the last 2 weeks; chills; slightly elevated fever; This spontaneous case was reported by a patient and describes the occurrence of INJECTION SITE PRURITUS (injection site was a little itchy), INJECTION SITE PAIN (soreness at the injection site), CHILLS (chills), PYREXIA (slightly elevated fever) and HEADACHE (a slight little headache for the last 2 weeks) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no historical condition was reported).    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Feb-2021, the patient experienced CHILLS (chills) and PYREXIA (slightly elevated fever). On an unknown date, the patient experienced INJECTION SITE PRURITUS (injection site was a little itchy), INJECTION SITE PAIN (soreness at the injection site) and HEADACHE (a slight little headache for the last 2 weeks). At the time of the report, INJECTION SITE PRURITUS (injection site was a little itchy), INJECTION SITE PAIN (soreness at the injection site), CHILLS (chills), PYREXIA (slightly elevated fever) and HEADACHE (a slight little headache for the last 2 weeks) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Large swelling on right arm within 15 minutes of vaccination. (@DPT site) resolved over 1 week.
Pt received first dose Pfizer vaccine, pt complains of Midsternal chest pressure and mild SOB. Pt presents with lightheadedness and complains of tunnel vision. After giving pretzels and water pt's symptoms subsided. Last VS: Time: 1730, HR: 80, R: 18, BP: 119/74, SPo2: 98%. Pt mentating appropriately.
Administered vaccine that was stored at temperature between -80 degree F to -84 degree F; Administered vaccine that was stored at temperature between -80 degree F to -84 degree F; This spontaneous case was reported by a nurse and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) and PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 076C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Nov-2021 at 4:00 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 02-Nov-2021 at 4:00 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) and PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.  Reporter stated that on an unknown date the facility had a temperature excursion for the Moderna COVID-19 vaccine and the excursion duration was 1 month. And also, the vaccine was stored in an ultra cold freezer at -82 degrees Fahrenheit. On 19-Nov-2021 the Moderna COVID-19 vials went from the super cold freezer to the refrigerator. 70 vials were in the ultra cold freezer, 8 vials were in the refrigerator. The vaccine was never refrozen. Number of vials impacted were 78 and none of the vials were punctured and there were no previous temperature excursions.   This case was linked to MOD-2021-402935 (Patient Link).
Significant redness and swelling at injection site, fever (101), nausea, body aches and ringing ears
This spontaneous report was received from a physician refers to an approximately 63 year old female patient. On 20-FEB-2013, the patient was vaccinated with ZOSTAVAX (Lot #, dose, route and indication were not reported). Physician reported that a patient was vaccinated with ZOSTAVAX and three days after vaccination, on 23-FEB-2013, the patient developed shingles and developed pain on her right torso along a dermatoma. The patient sought medical attention in office. The patient was treated with LIDODERM PATCH, VICODIN and NSAID. The outcome of shingles and pain on her right torso along a dermatoma was unknown. The relation between medication and events was unknown. The relation between medication and events was unknown. Additional information has been requested.
all sort of symptoms; migraines/headaches; she can't do anything physical and not able to work now; vomiting profusely; This spontaneous case was reported by an attorney and describes the occurrence of IMMUNISATION REACTION (all sort of symptoms), MIGRAINE (migraines/headaches), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (she can't do anything physical and not able to work now) and VOMITING (vomiting profusely) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.    On 27-Sep-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In September 2021, the patient experienced IMMUNISATION REACTION (all sort of symptoms), MIGRAINE (migraines/headaches), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (she can't do anything physical and not able to work now) and VOMITING (vomiting profusely). At the time of the report, IMMUNISATION REACTION (all sort of symptoms), MIGRAINE (migraines/headaches), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (she can't do anything physical and not able to work now) and VOMITING (vomiting profusely) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not reported. Patient thought it was a gallbladder, She went and saw surgeon. Patient was on a gallbladder diet. Patient used to be very active and now she could not do anything physical. No treatment information was provided by the reporter.
Booster; eye - hurting; developed pink eye; eye - would not stop watering; eye - swollen; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1, SINGLE), for Covid-19 immunization; Bnt162b2 (Dose 2, SINGLE), for Covid-19 immunization. The following information was reported: IMMUNISATION (non-serious), outcome "unknown", described as "Booster"; EYE PAIN (non-serious), outcome "unknown", described as "eye - hurting"; OCULAR HYPERAEMIA (non-serious), outcome "unknown", described as "developed pink eye"; LACRIMATION INCREASED (non-serious), outcome "unknown", described as "eye - would not stop watering"; EYE SWELLING (non-serious), outcome "unknown", described as "eye - swollen". Therapeutic measures were not taken as a result of eye swelling. Additional information: The patient received the booster on Wednesday and on Friday overnight patient developed pink eye in my right eye - it was swollen, hurting, red and would not stop. Also, patient was stated that as I'm writing this the swelling and redness remains, watering has stopped. Patient had no COVID prior vaccination and not COVID tested post vaccination. Patient had no Known allergies.   The lot number for bnt162b2 was not provided and will be requested during follow up.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101780341 Same product and event, different patient
Urticaria starting 4 hours after vaccine administration. Large hives covering all four extremities, chest, and back. Urticaria continued for 7 days. Treated with Benadryl every 4-6 hours 3.5ml.
about 5-10 minutes after administration, pt complained of tingling and weakness in the arm vaccination was given.  after monitoring the pt, she stated that the feeling was going away.  By the time of leaving the pharmacy about 20 minutes after initial complaint, pt stated that she was better.
Case number PHEH2015US026877, is an initial spontaneous report received from a nurse on 22 Dec 2015. This report refers to a 21 year old male patient. Past medication history and concomitant medication were not reported. The patient was vaccinated with FLUVIRIN (batch number: 1514501 and expiry date: May 2016) into left deltoid on 24 Oct 2015. It was reported that before administration the FLUVIRIN had a temperature excursion of 34 degrees. The reporter stated that she did not known why the refrigerator was out of temperature range for an unspecified amount of time overnight. She checked the temperature before she left for the day and when she arrived the next day the temperature was fine. It was a new refrigerator and there have not been any problems since the temperature excursion. No adverse reaction was experienced by the patient following the maladministration. No further information was provided. Follow up information received from the nurse on 26 Jan 2016: Reporter comment updated.
Given 10-4-12 pt present at PCP on 10/8/12 with rash on (L) deltoid size of a plum, red, hot to touch. Also general macular rash from neck to waist, itchy. Lower lip swelling went down with BENADRYL.
After receiving dose of COVID vaccine, patient reported difficulty breathing and became shaky.  Patient was transferred to wheelchair, given water and ice and was transferred by an RN to the ED.  Per ED MD, patient developed throat tightness, nausea, fluctuance a shin after COVID vaccine. Concern this could represent of a allergic reaction. Less likely vasovagal reaction as throat tightening would be very atypical. There were no signs of any angioedema, she has no rash, no wheezing, no chest pain. At this time she does not have signs of anaphylaxis. Patient's symptoms have completely resolved by the time of evaluation. Per MD, this could have been allergic reaction to the vaccine and therefore would not recommend that she received a 2nd dose. She is recommend to follow up with her primary care physician for re-evaluation and to discuss other options for vaccine.
possibly cause my appendicitis; This is a spontaneous report from a contactable Other HCP (patient). A 49-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: er8734) via an unspecified route of administration, administered in Arm Right on 15Apr2021 14:15 (at 49-year-old) as DOSE 2, SINGLE for covid-19 immunisation. Medical history included asthma, diverticulosis, obesity, hypertension, depression, benign prostatic hyperplasia, latex allergy. Covid prior vaccination was No. Other medications in two weeks: Yes, however, not specified. The patient previously took bnt162b2 DOSE 1, SINGLE (Lot No: ep7534) on 25Mar2021 02:15 PM at Left arm for covid-19 immunisation and allergies to tobrex. The patient reported that the bnt162b2 possibly cause his appendicitis from Jun2021. AE resulted in: Emergency room/department or urgent care, Hospitalization for 3 days, Life threatening illness (immediate risk of death from the event). Treatment for the event included Appendectomy. Covid tested post vaccination via Nasal Swab result=Negative. The outcome of the event was recovered.; Sender's Comments: Based on the information available and close temporal association, a possible contributory role of the suspect BNT162B2 cannot be excluded for the reported events . The case will be reassessed once new information is available   The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Stroke (blood clot in vein in left side of brain), occurred Wednesday March 17 at 5:15 pm. Immediately admitted to emergency room/stroke unit and given blood thinner IV and anti-seizure medicine
The patient noticed swelling and weakness in the left arm "a couple days later" after receiving FluAd. She has had difficulty lifting her arm since then as well. There is a red, raised nodule at the injection site that has not gone away.
Can hardly walk; Aches/ pain in her legs and thighs; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of GAIT DISTURBANCE (Can hardly walk) and PAIN IN EXTREMITY (Aches/ pain in her legs and thighs) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. C10M20A) for COVID-19 vaccination.     No Medical History was provided by the reporter.   On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 09-Feb-2021, the patient experienced GAIT DISTURBANCE (Can hardly walk) and PAIN IN EXTREMITY (Aches/ pain in her legs and thighs).   At the time of the report, GAIT DISTURBANCE (Can hardly walk) and PAIN IN EXTREMITY (Aches/ pain in her legs and thighs) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Treatment details included pain medication. Concomitant product use was not provided by the reporter.
Shingles/ shingles is still developing in different places from his lymph nodes to around his waist and around nerve endings; Has spots all over his body /Arm pits and waist rash; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Shingles/ shingles is still developing in different places from his lymph nodes to around his waist and around nerve endings) and RASH (Has spots all over his body /Arm pits and waist rash) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. U37C21A and 037C21A) for COVID-19 vaccination.     The patient's past medical history included Chickenpox.   On 29-Jun-2021 at 2:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Aug-2021 at 3:00 AM, the patient experienced RASH (Has spots all over his body /Arm pits and waist rash). On 01-Aug-2021 at 3:00 PM, the patient experienced HERPES ZOSTER (Shingles/ shingles is still developing in different places from his lymph nodes to around his waist and around nerve endings). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Shingles, at an unspecified dose and frequency and STEROIDS (oral) ongoing from 08-Aug-2021 for Shingles, at an unspecified dose and frequency. At the time of the report, HERPES ZOSTER (Shingles/ shingles is still developing in different places from his lymph nodes to around his waist and around nerve endings) and RASH (Has spots all over his body /Arm pits and waist rash) had not resolved.            No concomitant medications reported.  Shingles outbreak after second vaccine. Patient had arm pits and waist rash as first observation of the reaction   No other know causes.  Patient was  in recovery. Patient had  A+ blood type   Most recent FOLLOW-UP information incorporated above includes: On 09-Aug-2021: Follow up information received contains dose 2 information, vaccine facility information added, narrative supplement updated .
Initial case received from a physician on 01 February 2011. A 17-year-old male patient received an intramuscular injection of MENACTRA (lot number U2818AA) on 17 August 2009. On 21 January 2011 he presented to the emergency room with fever, vomiting, and petechia, and was diagnosed with meningococcal septicemia. He was transferred to the intensive care unit in critical condition, and died on 23 January 2011. Per the reporter, the patient had undergone blood cultures which were positive for meningococcal strain C. No medical history or concomitant medications were reported; the patient was not ill at the time of vaccination. Documents held by sender: None.
Rash on legs and abdomen and swelling of hands, feet and face starting the day after vaccination.
2nd pregnancy. Due with boy. 22 weeks pregnant at time of shot. On 12/25, broke out in full body hives starting behind ears and scalp and worked way down body. Still ongoing. Dr prescribed antihistamine, topical steroid and Pepcid. Waiting to start oral steroids given risk to pregnancy.
First dose- left arm pain two days; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 64 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 29Apr2021 14:30 (Lot number: EW0167) at the age of 64 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Sinuses - GER" (unspecified if ongoing). Concomitant medication(s) included: SIMETHICONE. Past drug history included: Sulfur, reaction(s): "Allergy:Sulfur"; Codeine, reaction(s): "Allergy:Codeine". The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 2021, outcome "recovering", described as "First dose- left arm pain two days". Therapeutic measures were not taken as a result of pain in extremity.  Additional information: The patient took Anthistamine/NasalDecongesta as other medications in two weeks. Facility where the most recent COVID-19 vaccine was administered: Other. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID. Since the vaccination, the patient has not been tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
8 days after my injection I developed a large red, swollen, hot, raised circle at the injection site.